Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 1;30(3):275-279.
doi: 10.1097/MNH.0000000000000696.

The epidermal growth factor receptor axis and kidney fibrosis

Raymond C Harris  1   2
Affiliations
Review

The epidermal growth factor receptor axis and kidney fibrosis

Raymond C Harris. Curr Opin Nephrol Hypertens. .

Abstract

Purpose of review: The aim of this study was to summarize recent findings about the role of the epidermal growth factor receptor (EGFR) in acute kidney injury and in progression of chronic kidney injury.

Recent findings: There is increasing evidence that EGFR activation occurs as a response to either ischemic or toxic kidney injury and EGFR signalling plays an important role in recovery of epithelial integrity. However, with incomplete recovery or in conditions predisposing to progressive glomerular and tubulointerstitial injury, aberrant persistent EGFR signalling is a causal mediator of progressive fibrotic injury. New studies have implicated activation of HIPPO/YAP signalling as a component of EGFR's actions in the kidney. There is also new evidence for sex disparities in kidney EGFR expression and activation after injury, with a male predominance that is mediated by androgens.

Summary: There is increasing evidence for an important role for EGFR signalling in mediation of kidney injury, raising the possibility that interruption of the signalling cascade could limit progression of development of progressive kidney fibrosis.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS of INTEREST

none

References

    1. Arteaga CL, Engelman JA: ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 2014, 25:282–303. - PMC - PubMed
    1. Kovacs E, Zorn JA, Huang Y, Barros T, Kuriyan J: A structural perspective on the regulation of the epidermal growth factor receptor. Annu Rev Biochem 2015, 84:739–764. - PMC - PubMed
    1. Zeng F, Singh AB, Harris RC: The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 2009, 315:602–610. - PMC - PubMed
    1. Chen J-C, Zeng F, Forrester S, Eguchi S, Zhang M-Z, Harris R: EXPRESSION AND FUNCTION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN PHYSIOLOGY AND DISEASE. Physiological Reviews 2016, 96:1025–1069. - PubMed
    1. Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Rodrigues Diez RR, Mas S, Lavoz C, Alique M, Pato J, Keri G, Ortiz A, et al.: Connective tissue growth factor is a new ligand of epidermal growth factor receptor. J Mol Cell Biol 2013, 5:323–335. - PubMed

Publication types

LinkOut - more resources